Berlin, Germany
Berlin, Germany

Time filter

Source Type

News Article | May 21, 2017
Site: www.PR.com

databridgemarketresearch.com presents "Global Pen Needles Market 2017.” It has accounted for USD 1.9 billion in 2016, and is expected to reach USD 4.5 billion by 2024 growing at a CAGR of 11.6% in the forecast period of 2017 to 2024. Dallas, TX, May 21, 2017 --( The Global Pen Needles Market is segmented on the basis of product type, product length, Usability, application, therapy, end-user and geography. Request for sample pages: http://databridgemarketresearch.com/reports/global-pen-needles-market/ The global pen needle market is segmented based on product type into standard and safety pen needles. The pen needles market is also segmented based on product length which varies from 4mm to 13mm in size. The pen needles segment by product length is long length, medium length and Nano length needles. Based on usability the global pen needles market is segmented into disposable and reusable pen needles. On the basis of application the global pen needles market is segmented into 3 indications diabetes, growth hormone deficiency and others. Based on the drug therapy the pen needles market is segmented into insulin, glucagon-like peptide-1 and growth hormones. Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. Read more: http://databridgemarketresearch.com/global-pen-needles-market-expected-reach-usd-3-6/ The major players operating in this market Becton, Dickinson and Company, ADW Diabetes, Novo Nordisk, A.Menarini Diagnostics, Ulticare, Ypsomed Holding AG, Facet Technologies, B. Braun Melsungen AG, Shanghai Neo-Medical Co. Ltd, HTL-Strefa S.A., Frank Healthcare Co., Ltd, Stat Medical Devices, Inc., Terumo Corporation, Domrex Pharma Inc., Vogt Medical Vertrieb GmbH, Artsana S.p.a, Eli Lilly, Owen Mumford Ltd, KD Medical GmbH Hospital Products, Allison Medical, Inc., Digital Medics Pty Ltd, and Ultimed, Inc. among others. About Data Bridge Market Research: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Dallas, TX, May 21, 2017 --( PR.com )-- The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.The Global Pen Needles Market is segmented on the basis of product type, product length, Usability, application, therapy, end-user and geography.Request for sample pages: http://databridgemarketresearch.com/reports/global-pen-needles-market/The global pen needle market is segmented based on product type into standard and safety pen needles.The pen needles market is also segmented based on product length which varies from 4mm to 13mm in size. The pen needles segment by product length is long length, medium length and Nano length needles.Based on usability the global pen needles market is segmented into disposable and reusable pen needles.On the basis of application the global pen needles market is segmented into 3 indications diabetes, growth hormone deficiency and others.Based on the drug therapy the pen needles market is segmented into insulin, glucagon-like peptide-1 and growth hormones.Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.Read more: http://databridgemarketresearch.com/global-pen-needles-market-expected-reach-usd-3-6/The major players operating in this market Becton, Dickinson and Company, ADW Diabetes, Novo Nordisk, A.Menarini Diagnostics, Ulticare, Ypsomed Holding AG, Facet Technologies, B. Braun Melsungen AG, Shanghai Neo-Medical Co. Ltd, HTL-Strefa S.A., Frank Healthcare Co., Ltd, Stat Medical Devices, Inc., Terumo Corporation, Domrex Pharma Inc., Vogt Medical Vertrieb GmbH, Artsana S.p.a, Eli Lilly, Owen Mumford Ltd, KD Medical GmbH Hospital Products, Allison Medical, Inc., Digital Medics Pty Ltd, and Ultimed, Inc. among others.About Data Bridge Market Research:Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Click here to view the list of recent Press Releases from Data Bridge Market Research


This report, Top 50 Companies in Point-of-Care Diagnostic Testing, profiles the following companies based on their size, product range, innovative capacity and influence in the market: Diagnostic tests performed outside the central laboratory or decentralized testing is generally known as point-of-care (POC).   The market is large and companies of various sizes are involved in the development and/or marketing of POC testing. The market is considered evolving with growth opportunity. Developing and developed markets alike have room to grow due to an aging population worldwide. Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics. In addition to profiles of these companies and recent revenue performance where financial information is available, the report provides market sizing and share for the entire POC test market. It also provides market data, including: - Alere - Abbott, Danaher Cepheid and Other Industry Developments - Size and Growth of the Point-of-Care Diagnostics Market, 2016-2021 - Market by Test Segment (Glucose, Pregnancy, FOB, Infectious Disease, Coagulation, Other) - Market by Self-Testing or Professional Testing - Market Share by Vendor - Company Profiling and Revenue Performance - Trends in the Industry Key Topics Covered: 1: Executive Summary - Introduction - Scope and Methodology - Size and Growth Of The Point-Of-Care Market - Trend - Alere and Abbott Merger - Trend - "Star Trek" POC Devices - Trend - Danaher Buys Cepheid - Trend - Retail Clinics - Companies In The POC Market 2: Top 50 Point Of Care Diagnostic Companies - Corporate Profiles - Abaxis, Inc. - Abbott Laboratories - Accriva Diagnostics - Accubiotech Co, Ltd. - Acon Laboratories, Inc - Alere Inc - Arkray - Atlas Genetics Ltd. - Atlas Link Biotech Co., Ltd. - Beckman Coulter, Inc. - Church & Dwight Co. Inc - Danaher Corporation - Dexcom, Inc - Dragerwerk Ag & Co.  - Eiken Chemical Co Ltd. - EKF Diagnostics - Enigma Diagnostics, Ltd. - Enterix, Inc - Exact Sciences - Helena Laboratories - Menarini Diagnostics - Meridian Bioscience, Inc - Micronics, Inc - Nova Biomedical, Corp. - Opko Health, Inc - Orasure Technologies, Inc. - Ortho Clinical Diagnostics - Polymer Technologies, Inc (Pts Diagnostics) - Roche Diagnostic Corporation - Samsung Healthcare - Sekisui Diagnostics - Siemens Healthineers - Sysmex Corporation - Trinity Biotech  - Veredus Laboratories  Ltd 3: POC Testing Market Share And Market Analysis For more information about this report visit http://www.researchandmarkets.com/research/9r93k4/top_50_companies Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/top-50-companies-in-point-of-care-diagnostic-testing-2017-with-size-and-growth-of-the-point-of-care-diagnostics-market-2016-2021---research-and-markets-300462487.html


News Article | May 25, 2017
Site: www.prlog.org

Databridgemarketresearch.com presents "Global Pen Needles is expected to worth at CAGR of 11.6%", is projected to reach USD 4.5 billion. -- The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.The Global Pen Needles Market is segmented into product type, product length, usability, application, therapy, and end-user and by geography.·         Standard Pen Needles·         Safety Pen Needles·         Nano Length·         Medium Length·         Long length·         Reusable Pen Needles·         Disposable Pen Needles·         Diabetes·         Growth Hormone Deficiency·         Insulin·         Glucagon-like peptide-1·         Growth Hormones·         Hospitals·         Clinics·         OTC·         Home HealthcareBased on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.·         Becton·         Dickinson and Company·         ADW Diabetes·         Novo Nordisk·         A.Menarini Diagnostics·         Ulticare·         Ypsomed Holding AG·         Facet Technologies·         B. Braun Melsungen AG·         Shanghai Neo-Medical Co. Ltd.·         HTL-Strefa S.A.·         Frank Healthcare Co., Ltd.·         Stat Medical Devices, Inc.·         Terumo Corporation·         Domrex Pharma Inc.·         Vogt Medical Vertrieb GmbH·         Artsana S.p.a·         Eli Lilly·         Owen Mumford Ltd·         KD Medical GmbH Hospital Products·         Allison Medical, Inc.·         Digital Medics Pty Ltd·         Ultimed, Inc.Data Bridge Market ResearchAmanora Chambers, Magarpatta Road,Hadapsar, Pune – 411028Tel: +1-888-387-2818Email: Sales@databridgemarketresearch.comVisit Data Bridge Blog@ http://databridgemarketresearch.com/blog/LinkedIn: https://www.linkedin.com/company/data-bridge-market-research


— The “Continuous Glucose Monitoring Systems Market - Medical Devices Pipeline Assessment, 2017” the report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Continuous Glucose Monitoring Systems pipeline products. Browse the 157 Tables and Figures, 70 Companies, Spread across 268 Pages Report Available at http://www.reportsnreports.com/contacts/discount.aspx?name=958615. Scope of the Report: Extensive coverage of the Continuous Glucose Monitoring Systems under development The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities The report reviews the major players involved in the development of Continuous Glucose Monitoring Systems and list all their pipeline projects The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage The report provides key clinical trial data of ongoing trials specific to pipeline products Recent developments in the segment / industry Companies are mentioned: A. Menarini Diagnostics S.r.l., Abbott Diabetes Care, Inc., Advanced Biosensors-Ohio, Llc, Advanced Medical Electronics Corporation, Arkal Medical, Inc., Bio-Impedance General Ltd., Biorasis, Inc., Biovotion AG, CALISTO MEDICAL, INC. (Inactive), Cardiff University Company, City, University of London, Columbia University, ConvaTec Group Plc, Cyber Medical Ltd., Debiotech SA, DexCom Inc, DirectSens GmbH, Echo Therapeutics Inc, Ecole Polytechnique Federale de Lausanne, eLutions Integrated, EyeSense GmbH, Flowsion A/S, Gili Medical Ltd, Globe Medical Tech Inc, and Others. Place Order to This Report at http://www.reportsnreports.com/purchase.aspx?name=958615. Continuous Glucose Monitoring Systems Market- Recent Developments : Mar 30, 2017: ConvaTec Expands Unomedical Manufacturing Technology Partnership with Medtronic Diabetes to Meet Growing Demand Mar 29, 2017: ConvaTec Group: Directorate changes Mar 28, 2017: Novo Acquires 19.95% Stake in Convatec from Nordic Capital and Avista for USD1.22 Billion Mar 28, 2017: ConvaTec: Proposed Directorate Changes Mar 27, 2017: Integrity Applications Board Appoints John Graham CEO and Chairman, Angela Strand Vice Chairman Mar 24, 2017: Medicare Announces Criteria Covering Dexcom G5 Mobile CGM for All People with Diabetes on Intensive Insulin Therapy Mar 21, 2017: Medtronic Prices Public Offering of 1.7% Notes Due 2019 for USD1 Billion Mar 21, 2017: Medtronic Prices Public Offering of 3.35% Notes Due 2027 for USD850 Million Mar 21, 2017: Medtronic Prices Public Offering of 4.625% Notes Due 2045 for USD150 Million Mar 21, 2017: Tenax Therapeutics Announces Year-End 2016 Financial Results and Provides Corporate Update Mar 14, 2017: PositiveID’s E-N-G Mobile Systems’ 2017 Bookings Through February Total $1.7 Million, Up More than 200% from Prior Quarter Mar 13, 2017: DexCom Appoints Richard Collins to Board of Directors Mar 08, 2017: Tandem Diabetes Care Reports 2016 Financial Results Continuous Glucose Monitoring Systems Market- Recent Developments for 2017, January and February is also mentioned. List of Tables Table 1: Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development Table 2: Continuous Glucose Monitoring Systems - Pipeline Products by Segment Table 3: Continuous Glucose Monitoring Systems - Pipeline Products by Territory Table 4: Continuous Glucose Monitoring Systems - Pipeline Products by Regulatory Path Table 5: Continuous Glucose Monitoring Systems - Pipeline Products by Estimated Approval Date And more List of Figures Figure 1: Continuous Glucose Monitoring Systems - Pipeline Products by Stage of Development Figure 2: Continuous Glucose Monitoring Systems - Pipeline Products by Territory Figure 3: Continuous Glucose Monitoring Systems - Pipeline Products by Regulatory Path Figure 4: Continuous Glucose Monitoring Systems - Pipeline Products by Estimated Approval Date Figure 5: Continuous Glucose Monitoring Systems - Ongoing Clinical Trials Complete Table of Content is Available at Continuous Glucose Monitoring Systems - Medical Devices Pipeline Assessment, 2017. About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. For more information, please visit http://www.reportsnreports.com/reports/958615-continuous-glucose-monitoring-systems-medical-devices-pipeline-assessment-2017.html


News Article | November 16, 2016
Site: www.newsmaker.com.au

MarketStudyReport.com adds “Global Professional Diagnostics Market 2016-2020” new report to its research database. The report spread across 86 pages with table and figures in it. The research analysts forecast the global professional diagnostics market to grow at a CAGR of 6.76% during the period 2016-2020. About Professional Diagnostics The global professional diagnostics market is expected to grow at a high rate in the forecast period. Factors such as increasing aging population and rise in incidence and prevalence of chronic diseases and infections are driving the market. Cancer, tuberculosis, malaria, diabetes, and cardiovascular diseases are the main factors for the increasingly diagnosed population. In addition, increasing public awareness, rapid technological innovations, product approvals from regulatory authorities, and new product launches are expected to have a positive impact on the market over the next few years. Covered in this report The report covers the present scenario and the growth prospects of the global professional diagnostics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of in-vitro diagnostics (IVD) instruments. The market is divided into the following segments based on geography: Americas APAC EMEA Research report, Global Professional Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Browse full table of contents and data tables at https://www.marketstudyreport.com/reports/global-professional-diagnostics-market-2016-2020/        Key vendors Abbott Diagnostics Danaher Roche Diagnostics Siemens Healthcare Thermo Fisher Scientific Other prominent vendors A&T Corporation Menarini Diagnostics Abaxis Abcam Accriva Diagnostics Acon Laboratories Affymetrix Ahram Biosystem ARKRAY AsuraGen Biocartis Bio-Rad Laboratories CellaVision Cepheid Chembio Diagnostic Systems Clarity Diagnostics Corgenix DiagCor Drucker Diagnostics EKF Molecular Diagnostics Erba Diagnostics Green Cross Medis Helena Laboratories Hologic HORIBA Instrumentation Laboratory i-Sens Landwind Medical Mindray Nihon Kohden Nipro Diagnostics Randox Laboratories Sekisui Medical Sienco Sinduri Biotec Snibe Diagnostics Stago Trivitron Healthcare Market driver Growing focus on diagnosing life-threatening conditions boosts POCT segment. For a full, detailed list, view our report Market challenge Industry consolidation posing threat to new entrants. For a full, detailed list, view our report Market trend Renting and leasing of professional diagnostics instruments. For a full, detailed list, view our report Key questions answered in this report What will the market size be in 2020 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors? To receive personalized assistance, write to us @ [email protected] with the report title in the subject line along with your questions or call us at +1 866-764-2150

Loading Menarini Diagnostics collaborators
Loading Menarini Diagnostics collaborators